Hong Kong Medical Devices & Specialty Drugs
Expert insights about medical devices and specialty drugs from top distributors in Hong Kong and Greater China
The U.S. Commercial Service in Hong Kong recently met with two leading distributors of medical devices and pharmaceutical products that are looking to supply more U.S. products into the Hong Kong and Macau markets.
Kerry Medical has a 35-year medical distributorship history in Hong Kong and in Macau. Kerry’s broad network of sales channels includes public and private hospitals, nursing homes, care centers, clinics, labs, and pharmacies. In addition, the firm’s online platform is one of the leading medical distribution websites in Hong Kong. Kerry’s core services include product warehousing, secondary packaging (e.g. to insert medical instructions/labeling as required by the local government), distribution logistics, and direct delivery of medical-related products to customers across Hong Kong, Macau. In addition, Kerry Medical also provides services such as account relationship management, local regulatory registrations, strategizing on tender submissions, and marketing promotion events. The company has multiple self-owned warehouses and a dedicated truck fleet for delivery and distribution.
DKSH Hong Kong is another major medical device and specialty drug distributor for Hong Kong and Greater China. The company offers market development and expansion services for healthcare and medical device companies looking to enter the market here. According to DKSH, there is growing demand for non-invasive medical devices, especially innovative products that will help hospital systems identify cost savings without compromising quality.
Both companies stated that top prospects for the Hong Kong and Macau markets include hospital-grade consumables, rehabilitation products and equipment, and health supplements. Specialty drugs to treat uncommon disorders such as oncology drugs and other non-generic targeted medicines are also in demand here. Telemedicine services and equipment to support telemedicine such as MRI and CT scanning machines are both booming in Hong Kong and Macau and will only increase in coming years.
Hong Kong’s sizable market, its proximity to mainland China and Southeast Asia, and the fact that it recognizes FDA approvals for medical/pharmaceutical products here make the territory an ideal launching pad for American companies looking to gain a foothold in Asia and the greater Indo-Pacific. U.S. firms interested in connecting with Kerry Medical or DKSH Hong Kong — or to discuss their specific company products and their suitability for the greater Hong Kong market — should reach out to the U.S. Commercial Service Hong Kong at Office.Hongkong@trade.gov.